登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式(希尔记法):
C7H17NO6S
化学文摘社编号:
分子量:
243.28
EC Number:
249-954-1
UNSPSC Code:
12161700
MDL number:
Beilstein/REAXYS Number:
2452420
assay
≥99.0% (T)
ign. residue
≤0.1% (as SO4)
loss
≤0.1% loss on drying, 110 °C
useful pH range
7.7-9.1
pKa
8.4
mp
230-235 °C (dec.)
solubility
H2O: 0.5 M at 20 °C, clear
anion traces
chloride (Cl-): ≤50 mg/kg, sulfate (SO42-): ≤50 mg/kg
cation traces
Ca: ≤50 mg/kg, Cd: ≤5 mg/kg, Co: ≤5 mg/kg, Cr: ≤5 mg/kg, Cu: ≤5 mg/kg, Fe: ≤5 mg/kg, K: ≤50 mg/kg, Mg: ≤5 mg/kg, Mn: ≤5 mg/kg, Na: ≤50 mg/kg, Ni: ≤5 mg/kg, Pb: ≤5 mg/kg, Zn: ≤5 mg/kg
SMILES string
OCC(CO)(CO)NCCCS(O)(=O)=O
InChI
1S/C7H17NO6S/c9-4-7(5-10,6-11)8-2-1-3-15(12,13)14/h8-11H,1-6H2,(H,12,13,14)
InChI key
YNLCVAQJIKOXER-UHFFFAOYSA-N
Still not finding the right product?
Explore all of our products under TAPS
存储类别
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
>230.0 °F - closed cup
flash_point_c
> 110 °C - closed cup
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
新产品
此项目有
Z Zeng et al.
Analytical biochemistry, 252(1), 110-114 (1997-11-05)
High-resolution capillary electrophoresis sizing of preformed complexes of bis-intercalating fluorescent dyes with double-stranded DNA has been demonstrated using hydroxyethylcellulose and 3-[tris-(hydroxymethyl) methylamino]-1-propanesulfonic acid-tetrapentylammonium (Taps-NPe+4) buffers (S. M. Clark and R. A. Mathies, Anal. Chem. 69, 1355-1363, 1997). Such capillary electrophoresis
D Liang et al.
Electrophoresis, 21(17), 3600-3608 (2001-03-29)
A new method to introduce the concentration gradient into the capillary has been developed and its application to DNA capillary electrophoresis is presented. The concentration gradient produced by mixing 5% w/v polyacrylamide-co-poly(N-dimethylacrylamide) (PAM-co-PDMA) solution and 1 x Tris/N-tris(hydroxymethyl)methyl-3-amino-propanesulfonic acid/EDTA (TT)
Seung-ick Oh et al.
TheScientificWorldJournal, 2014, 957548-957548 (2014-07-06)
Somatic cells were directly converted to functional neurons through the use of a combination of transcription factors, including Ascl1, Brn2, and Myt1l. However, a major limitation is the lack of a reliable source of cell-replacement therapy for neurological diseases. Here